Impact of adjuvant treatment modalities on the management of patients with stages I-II endometrial stromal sarcoma

Annals of Oncology

Volumn 21, Issue 10, 2010, Pages 2102-2106

  Malouf, G G ^a   Duclos, J ^a   Rey, A ^a   Duvillard, P ^a   Lazar, V ^a   Haie Meder, C ^a   Balleyguier, C ^a   Morice, P ^a   Lhomme C ^a   Pautier, P ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Adjuvant treatment; Endometrial stromal sarcoma; Hormonal therapy; Prognosis; Radiotherapy; Recurrence

Indexed keywords

AROMATASE INHIBITOR; CISPLATIN; ESTROGEN RECEPTOR; MEGESTROL ACETATE; PROGESTERONE RECEPTOR;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER INVASION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE SURVEILLANCE; ENDOMETRIUM SARCOMA; EVENT FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; HYSTERECTOMY; MAJOR CLINICAL STUDY; METASTASIS; MONOTHERAPY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE FREE SURVIVAL; SALPINGOOOPHORECTOMY;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRACHYTHERAPY; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; ENDOMETRIAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYSTERECTOMY; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PELVIC NEOPLASMS; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SARCOMA, ENDOMETRIAL STROMAL; SURVIVAL RATE;

EID: 77957128562     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdq064     Document Type: Article

References (24)

1. Echt G, Jepson J, Steel J et al. Treatment of uterine sarcomas. Cancer 1990; 66: 35-39.
2. Pautier P, Genestie C, Rey A et al. Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma. Cancer 2000; 88: 1425-1431.
3. Norris HJ, Roth E, Taylor HB. Mesenchymal tumors of the uterus. II. A clinical and pathologic study of 31 mixed mesodermal tumors. Obstet Gynecol 1966; 28: 57-63.
4. Oliva E, Clement PB, Young RH. Endometrial stromal tumors: an update on a group of tumors with a protean phenotype. Adv Anat Pathol 2000; 7: 257-281.
5. Leath CA, 3rd, Huh WK, Hyde J Jr. et al. A multi-institutional review of outcomes of endometrial stromal sarcoma. Gynecol Oncol 2007; 105: 630-634.
6. Gadducci A, Sartori E, Landoni F et al. Endometrial stromal sarcoma: analysis of treatment failures and survival. Gynecol Oncol 1996; 63: 247-253.
7. Li AJ, Giuntoli RL, 2nd, Drake R et al. Ovarian preservation in stage I low-grade endometrial stromal sarcomas. Obstet Gynecol 2005; 106: 1304-1308.
8. Chu MC, Mor G, Lim C et al. Low-grade endometrial stromal sarcoma: hormonal aspects. Gynecol Oncol 2003; 90: 170-176.
9. Maluf FC, Sabbatini P, Schwartz L et al. Endometrial stromal sarcoma: objective response to letrozole. Gynecol Oncol 2001; 82: 384-388.
10. Chang KL, Crabtree GS, Lim-Tan SK et al. Primary uterine endometrial stromal neoplasms. A clinicopathologic study of 117 cases. Am J Surg Pathol 1990; 14: 415-438.
11. Amant F, De Knijf A, Van Calster B et al. Clinical study investigating the role of lymphadenectomy, surgical castration and adjuvant hormonal treatment in endometrial stromal sarcoma. Br J Cancer 2007; 97: 1194-1199.
12. Kim WY, Lee JW, Choi CH et al. Low-grade endometrial stromal sarcoma: a single center's experience with 22 cases. Int J Gynecol Cancer 2008; 18: 1084-1089.
13. Reich O, Regauer S. Hormonal therapy of endometrial stromal sarcoma. Curr Opin Oncol 2007; 19: 347-352.
14. Piver MS, Rutledge FN, Copeland L et al. Uterine endolymphatic stromal myosis: a collaborative study. Obstet Gynecol 1984; 64: 173-178.
15. Gloor E, Schnyder P, Cikes M et al. Endolymphatic stromal myosis. Surgical and hormonal treatment of extensive abdominal recurrence 20 years after hysterectomy. Cancer 1982; 50: 1888-1893.
16. Chan JK, Kawar NM, Shin JY et al. Endometrial stromal sarcoma: a population-based analysis. Br J Cancer 2008; 99: 1210-1215.
17. Li N, Wu LY, Zhang HT et al. Treatment options in stage I endometrial stromal sarcoma: a retrospective analysis of 53 cases. Gynecol Oncol 2008; 108: 306-311.
18. Weitmann HD, Knocke TH, Kucera H et al. Radiation therapy in the treatment of endometrial stromal sarcoma. Int J Radiat Oncol Biol Phys 2001; 49: 739-748.
19. Vongtama V, Karlen JR, Piver SM et al. Treatment, results and prognostic factors in stage I and II sarcomas of the corpus uteri. AJR Am J Roentgenol 1976; 126: 139-147.
20. Mansi JL, Ramachandra S, Wiltshaw E et al. Endometrial stromal sarcomas. Gynecol Oncol 1990; 36: 113-118.
21. Bodner K, Bodner-Adler B, Obermair A et al. Prognostic parameters in endometrial stromal sarcoma: a clinicopathologic study in 31 patients. Gynecol Oncol 2001; 81: 160-165.
22. Reich O, Regauer S, Urdl W et al. Expression of oestrogen and progesterone receptors in low-grade endometrial stromal sarcomas. Br J Cancer 2000; 82: 1030-1034.
23. Leunen M, Breugelmans M, De Sutter P et al. Low-grade endometrial stromal sarcoma treated with the aromatase inhibitor letrozole. Gynecol Oncol 2004; 95: 769-771.
24. Reich O, Regauer S. Estrogen replacement therapy and tamoxifen are contraindicated in patients with endometrial stromal sarcoma. Gynecol Oncol 2006; 102: 413-414; author reply 414.